Cargando…

Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts

Detalles Bibliográficos
Autores principales: Moon, Jeonghyeon, Lee, Seon-yeong, Choi, Jeong Won, Lee, A. Ram, Yoo, Jin Hee, Moon, Su-Jin, Park, Sung-Hwan, Cho, Mi-La
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218406/
https://www.ncbi.nlm.nih.gov/pubmed/34154617
http://dx.doi.org/10.1186/s12967-021-02916-0
_version_ 1783710758143524864
author Moon, Jeonghyeon
Lee, Seon-yeong
Choi, Jeong Won
Lee, A. Ram
Yoo, Jin Hee
Moon, Su-Jin
Park, Sung-Hwan
Cho, Mi-La
author_facet Moon, Jeonghyeon
Lee, Seon-yeong
Choi, Jeong Won
Lee, A. Ram
Yoo, Jin Hee
Moon, Su-Jin
Park, Sung-Hwan
Cho, Mi-La
author_sort Moon, Jeonghyeon
collection PubMed
description
format Online
Article
Text
id pubmed-8218406
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82184062021-06-23 Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts Moon, Jeonghyeon Lee, Seon-yeong Choi, Jeong Won Lee, A. Ram Yoo, Jin Hee Moon, Su-Jin Park, Sung-Hwan Cho, Mi-La J Transl Med Correction BioMed Central 2021-06-21 /pmc/articles/PMC8218406/ /pubmed/34154617 http://dx.doi.org/10.1186/s12967-021-02916-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Moon, Jeonghyeon
Lee, Seon-yeong
Choi, Jeong Won
Lee, A. Ram
Yoo, Jin Hee
Moon, Su-Jin
Park, Sung-Hwan
Cho, Mi-La
Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts
title Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts
title_full Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts
title_fullStr Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts
title_full_unstemmed Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts
title_short Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts
title_sort correction to: metformin ameliorates scleroderma via inhibiting th17 cells and reducing mtor-stat3 signaling in skin fibroblasts
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218406/
https://www.ncbi.nlm.nih.gov/pubmed/34154617
http://dx.doi.org/10.1186/s12967-021-02916-0
work_keys_str_mv AT moonjeonghyeon correctiontometforminamelioratessclerodermaviainhibitingth17cellsandreducingmtorstat3signalinginskinfibroblasts
AT leeseonyeong correctiontometforminamelioratessclerodermaviainhibitingth17cellsandreducingmtorstat3signalinginskinfibroblasts
AT choijeongwon correctiontometforminamelioratessclerodermaviainhibitingth17cellsandreducingmtorstat3signalinginskinfibroblasts
AT leearam correctiontometforminamelioratessclerodermaviainhibitingth17cellsandreducingmtorstat3signalinginskinfibroblasts
AT yoojinhee correctiontometforminamelioratessclerodermaviainhibitingth17cellsandreducingmtorstat3signalinginskinfibroblasts
AT moonsujin correctiontometforminamelioratessclerodermaviainhibitingth17cellsandreducingmtorstat3signalinginskinfibroblasts
AT parksunghwan correctiontometforminamelioratessclerodermaviainhibitingth17cellsandreducingmtorstat3signalinginskinfibroblasts
AT chomila correctiontometforminamelioratessclerodermaviainhibitingth17cellsandreducingmtorstat3signalinginskinfibroblasts